Maturitas
Volume 57, Issue 1 , Pages 39-41, 20 May 2007

Primary prevention of breast cancer: New approaches

San Francisco Coordinating Center, California Pacific Medical Center Research Institute and the University of California, San Francisco, CA, United States

published online 09 March 2007.

Abstract 

Lifestyle changes, such as exercise, might reduce the risk of breast cancer. Tamoxifen and raloxifene reduce the risk of breast cancer but have potential adverse effects and, therefore, should be considered by women at high risk of breast cancer. Breast density is a strong risk factor for breast cancer; assessment of breast density can be combined with risk factors to estimate a woman's risk of breast cancer. I propose that a woman's risk of breast cancer be assessed along with her screening mammogram with consideration of chemoprevention for those at high risk.

Keywords: Tamoxifen, Raloxifene, Mammogram

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0378-5122(07)00070-9

doi:10.1016/j.maturitas.2007.02.010

Maturitas
Volume 57, Issue 1 , Pages 39-41, 20 May 2007

Article Tools

* Image Usage & Resolution